Time in sec to remove tail from noxious stimuli under test conditions in the first tail flick before self admin
Tags: Behavior · Heroin
Project: u01_peter_kalivas
2 loci · 2 genes with independent associations · 2 total associated genes
| # | Chr | Start pos | End pos | # assoc genes | # joint models | Best TWAS P | Best GWAS P | Cond GWAS P | Joint genes |
|---|---|---|---|---|---|---|---|---|---|
| 1 | chr1 | 68674594 | 70070028 | 1 | 1 | 1.66e-07 | 8.20e-02 | 1.87e-55 | Rdh13 |
| 2 | chr1 | 72799368 | 74100561 | 1 | 1 | 1.40e-07 | 3.48e-02 | 7.29e-17 | Zfp329 |
| Tissue | RNA modality | # hits | % hits/tests | Avg chisq |
|---|---|---|---|---|
| Adipose | alternative polyA | 0 | 0 | 1.01 |
| Adipose | alternative TSS | 0 | 0 | 0.96 |
| Adipose | gene expression | 0 | 0 | 1.01 |
| Adipose | isoform ratio | 0 | 0 | 0.94 |
| Adipose | intron excision ratio | 0 | 0 | 0.92 |
| Adipose | mRNA stability | 0 | 0 | 1.02 |
| BLA | alternative polyA | 0 | 0 | 1.04 |
| BLA | alternative TSS | 0 | 0 | 0.86 |
| BLA | gene expression | 0 | 0 | 1 |
| BLA | isoform ratio | 0 | 0 | 0.97 |
| BLA | intron excision ratio | 0 | 0 | 0.96 |
| BLA | mRNA stability | 0 | 0 | 0.96 |
| Brain | alternative polyA | 0 | 0 | 1 |
| Brain | alternative TSS | 0 | 0 | 0.93 |
| Brain | gene expression | 0 | 0 | 1.01 |
| Brain | isoform ratio | 0 | 0 | 0.99 |
| Brain | intron excision ratio | 0 | 0 | 0.96 |
| Brain | mRNA stability | 0 | 0 | 1.01 |
| Eye | alternative polyA | 0 | 0 | 1.04 |
| Eye | alternative TSS | 0 | 0 | 1.19 |
| Eye | gene expression | 0 | 0 | 0.98 |
| Eye | isoform ratio | 0 | 0 | 1.01 |
| Eye | intron excision ratio | 0 | 0 | 0.91 |
| Eye | mRNA stability | 0 | 0 | 0.92 |
| IL | alternative polyA | 0 | 0 | 0.95 |
| IL | alternative TSS | 0 | 0 | 0.93 |
| IL | gene expression | 0 | 0 | 0.98 |
| IL | isoform ratio | 0 | 0 | 0.97 |
| IL | intron excision ratio | 0 | 0 | 0.94 |
| IL | mRNA stability | 0 | 0 | 0.97 |
| LHb | alternative polyA | 0 | 0 | 0.86 |
| LHb | alternative TSS | 0 | 0 | 0.86 |
| LHb | gene expression | 0 | 0 | 0.98 |
| LHb | isoform ratio | 0 | 0 | 0.97 |
| LHb | intron excision ratio | 0 | 0 | 0.9 |
| LHb | mRNA stability | 0 | 0 | 1.02 |
| Liver | alternative polyA | 0 | 0 | 0.91 |
| Liver | alternative TSS | 0 | 0 | 0.96 |
| Liver | gene expression | 0 | 0 | 1.01 |
| Liver | isoform ratio | 0 | 0 | 0.96 |
| Liver | intron excision ratio | 1 | 0 | 0.95 |
| Liver | mRNA stability | 0 | 0 | 1.01 |
| NAcc | alternative polyA | 0 | 0 | 0.98 |
| NAcc | alternative TSS | 0 | 0 | 0.94 |
| NAcc | gene expression | 0 | 0 | 1.01 |
| NAcc | isoform ratio | 0 | 0 | 0.96 |
| NAcc | intron excision ratio | 0 | 0 | 0.95 |
| NAcc | mRNA stability | 0 | 0 | 0.97 |
| OFC | alternative polyA | 0 | 0 | 0.98 |
| OFC | alternative TSS | 0 | 0 | 0.87 |
| OFC | gene expression | 0 | 0 | 0.98 |
| OFC | isoform ratio | 0 | 0 | 1.04 |
| OFC | intron excision ratio | 0 | 0 | 0.93 |
| OFC | mRNA stability | 0 | 0 | 0.96 |
| PL | alternative polyA | 1 | 0 | 0.99 |
| PL | alternative TSS | 0 | 0 | 0.93 |
| PL | gene expression | 0 | 0 | 1.04 |
| PL | isoform ratio | 0 | 0 | 0.98 |
| PL | intron excision ratio | 0 | 0 | 0.94 |
| PL | mRNA stability | 0 | 0 | 1 |
| pVTA | alternative polyA | 0 | 0 | 0.98 |
| pVTA | alternative TSS | 0 | 0 | 0.87 |
| pVTA | gene expression | 0 | 0 | 1.01 |
| pVTA | isoform ratio | 0 | 0 | 0.98 |
| pVTA | intron excision ratio | 0 | 0 | 0.97 |
| pVTA | mRNA stability | 0 | 0 | 1.03 |
| RMTg | alternative polyA | 0 | 0 | 0.82 |
| RMTg | alternative TSS | 0 | 0 | 0.89 |
| RMTg | gene expression | 0 | 0 | 0.98 |
| RMTg | isoform ratio | 0 | 0 | 0.93 |
| RMTg | intron excision ratio | 0 | 0 | 0.99 |
| RMTg | mRNA stability | 0 | 0 | 0.99 |